Clinical Trials · NCT07629401

Pre-approval Expanded Access of Retatrutide (LY3437943)

AvailableN/ARetatrutide (Unclear)
Phase
N/A
Recruitment status
Available
Sponsor
Eli Lilly and Company
Enrollment
0
Start date
Not specified
Locations
See registry
Primary endpoint
Study in Obesity
View Retatrutide compound reference